Abbreviations
- BSI:
-
Bloodstream infections
- CPK:
-
Creatine phosphokinase
- ECOFF:
-
Epidemiological cut-off
- EUCAST:
-
European Committee on Antimicrobial Susceptibility Testing
- FDA:
-
Food and Drug Administration
- HLAR:
-
High-level aminoglycoside resistance
- IAI:
-
Intra-abdominal infection
- ICU:
-
Intensive care unit
- IE:
-
Infective endocarditis
- LFTs:
-
Liver function tests
- MIC:
-
Minimum inhibitory concentration
- MDR:
-
Multidrug resistant
- PCR:
-
Polymerase chain reaction
- PBP:
-
Penicillin-binding protein
- VRE:
-
Vancomycin-resistant entercococcus
References
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N, WHO Pathogens Priority List Working Group (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318–327
Faron ML, Ledeboer NA, Buchan BW (2016) Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant enterococcus in the health care setting. J Clin Microbiol 54(10):2436–2447
European Centre for Disease Prevention and Control (2018) European Center for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2017. http://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2017. Accessed 23 Sept 2019
Bender JK, Cattoir V, Hegstad K, Sadowy E, Coque TM, Westh H, Hammerum AM, Schaffer K, Burns K, Murchan S, Novais C, Freitas AR, Peixe L, Del Grosso M, Pantosti A, Werner G (2018) Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother 40:25–39
De Angelis G, Cataldo MA, De Waure C, Venturiello S, La Torre G, Cauda R, Carmeli Y, Tacconelli E (2014) Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother 69(5):1185–1192
Nigo M, Munita JM, Arias CA, Murray BE (2014) What’s new in the treatment of enterococcal endocarditis? Curr Infect Dis Rep 16(10):431
Smith JR, Barber KE, Raut A, Aboutaleb M, Sakoulas G, Rybak MJ (2015) β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother 70(6):1738–1743
Miller WR, Murray BE, Rice LB, Arias CA (2016) Vancomycin-resistant enterococci: therapeutic challenges in the 21st century. Infect Dis Clin N Am 30(2):415–439
Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, Rosengart MR, Chang PK, O’Neill PJ, Mollen KP, Huston JM, Diaz JJ Jr, Prince JM (2017) The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect 18(1):1–76
Kanjilal S, Kalil AC, Klompas M (2018) What is the best treatment for vancomycin-resistant enterococcal bloodstream infections? Crit Care Med 46(10):1700–1703
Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi J, Munita JM, Hasbun R, Arias CA (2016) Influence of minimum inhibitory concentration in clinical outcomes of enterococcus faecium bacteremia treated with daptomycin: is it time to change the breakpoint? Clin Infect Dis 62(12):1514–1520
Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL (2018) A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clin Infect Dis 67(2):303–309
Baddour M, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, Barsic B, Lockhart PB, Gewitz MH, Levison ME, Bolger AF, Steckelberg JM, Baltimore RS, Fink AM, O’Gara P, Tauberti KA, on behalf of the American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council (2015) Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications. Circulation 132(15):1435–1486
Funding
Partially supported by CIBERES, Instituto de Salud Carlos III (CB06-06-036), Madrid, Spain.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest: JR, LC, VKE.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Rello, J., Campogiani, L. & Eshwara, V.K. Understanding resistance in enterococcal infections. Intensive Care Med 46, 353–356 (2020). https://doi.org/10.1007/s00134-019-05875-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-019-05875-9